Ocugen Inc. (OCGN): Price and Financial Metrics

Ocugen Inc. (OCGN): $0.76

0.05 (+6.92%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add OCGN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#263 of 301

in industry

OCGN Price/Volume Stats

Current price $0.76 52-week high $2.03
Prev. close $0.71 52-week low $0.52
Day low $0.68 Volume 8,339,400
Day high $0.81 Avg. volume 3,953,182
50-day MA $0.67 Dividend yield N/A
200-day MA $0.88 Market Cap 221.48M

OCGN Stock Price Chart Interactive Chart >


Ocugen Inc. (OCGN) Company Bio


Ocugen, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of transformative therapies to cure blindness diseases. The company's pipeline product includes OCU200, a novel fusion protein that is in preclinical development stage for the treatment of wet AMD, diabetic retinopathy, and diabetic macular edema; OCU400 to treat retinitis pigmentosa, a group of rare genetic disorders; and OCU410, which is in preclinical development stage for the treatment of dry AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing. The company is headquartered in Malvern, Pennsylvania.


OCGN Latest News Stream


Event/Time News Detail
Loading, please wait...

OCGN Latest Social Stream


Loading social stream, please wait...

View Full OCGN Social Stream

OCGN Price Returns

1-mo 11.86%
3-mo 5.86%
6-mo -16.59%
1-year -60.21%
3-year -63.11%
5-year 149.18%
YTD -5.59%
2024 40.00%
2023 -55.77%
2022 -71.43%
2021 148.63%
2020 251.92%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!